[Clinical effect of cefotetan against infectious diseases in obstetrics and gynaecology].
Clinical study on cefotetan (CTT), a new cephamycin antibiotic, was carried out and the following results were obtained. CTT was intravenously administered at a daily dose of 2 to 4 g to 24 cases including 10 cases with intrauterine infection, 2 cases with adnexitis, 6 cases with intrapelvic infection and 6 cases with extragenital infection. Marked response was seen in 8 cases, moderate response in 15 and no response in 1. Neither side effects nor abnormal values in clinical laboratory tests were observed.